SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006266
Filing Date
2018-08-03
Accepted
2018-08-02 17:59:46
Documents
42
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20180630x10q.htm 10-Q 1053989
2 EX-31.1 mrns-20180630ex311eebc09.htm EX-31.1 15228
3 EX-31.2 mrns-20180630ex3120920a5.htm EX-31.2 15371
4 EX-32.1 mrns-20180630ex32125b4ed.htm EX-32.1 9448
5 GRAPHIC mrns20180630x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-18-006266.txt   2940545

Data Files

Seq Description Document Type Size
6 EX-101.INS mrns-20180630.xml EX-101.INS 477604
7 EX-101.SCH mrns-20180630.xsd EX-101.SCH 17684
8 EX-101.CAL mrns-20180630_cal.xml EX-101.CAL 28211
9 EX-101.DEF mrns-20180630_def.xml EX-101.DEF 56522
10 EX-101.LAB mrns-20180630_lab.xml EX-101.LAB 201469
11 EX-101.PRE mrns-20180630_pre.xml EX-101.PRE 134160
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 18989804
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences